Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in

Frank Niessen1, Thomas Hilger, Mathias Hoehn

  • 1Department of Experimental Neurology, Max-Planck-Institute for Neurological Research, Gleueler Strasse 50, D-50931 Cologne, Germany.

Stroke
|July 5, 2003
PubMed
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...